Haemonetics
(NYSE:HAE)
$74.16
1.18[1.62%]
At close: Mar 1
$74.16
0[0.00%]
After Hours: 4:00PM EDT

GET A REPORT ON HAE SENT RIGHT TO YOUR INBOX

Haemonetics Stock (NYSE:HAE), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.
Consensus Rating1
Outperform
Highest Price Target1
$115.00
Lowest Price Target1
$60.00
Consensus Price Target1
$76.82

Analyst Rating Summary1

Analyst Ratings
Oct 23
1
Nov 23
1
Feb
1
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Barrington Research
Citigroup
Morgan Stanley
JMP Securities
Mizuho

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Haemonetics

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
02/13/2024HAEBuy Now
Haemonetics
$74.1641.59%Barrington Research
Michael Petusky
→ $105ReiteratesOutperform → OutperformGet Alert
11/03/2023HAEBuy Now
Haemonetics
$74.1641.59%Barrington Research
Michael Petusky
$114 → $105MaintainsOutperformGet Alert
10/02/2023HAEBuy Now
Haemonetics
$74.1626.75%Citigroup
Joanne Wuensch
$90 → $94MaintainsNeutralGet Alert
08/09/2023HAEBuy Now
Haemonetics
$74.1653.72%Barrington Research
Michael Petusky
$111 → $114MaintainsOutperformGet Alert
05/12/2023HAEBuy Now
Haemonetics
$74.1649.68%Barrington Research
Michael Petusky
$103 → $111MaintainsOutperformGet Alert
05/12/2023HAEBuy Now
Haemonetics
$74.1629.45%Morgan Stanley
Drew Ranieri
$88 → $96MaintainsEqual-WeightGet Alert
05/12/2023HAEBuy Now
Haemonetics
$74.1655.07%JMP Securities
David Turkaly
$105 → $115MaintainsMarket OutperformGet Alert
02/08/2023HAEBuy Now
Haemonetics
$74.1618.66%Morgan Stanley
Drew Ranieri
$84 → $88MaintainsEqual-WeightGet Alert
02/08/2023HAEBuy Now
Haemonetics
$74.1628.1%Citigroup
Joanne Wuensch
$92 → $95MaintainsNeutralGet Alert
02/08/2023HAEBuy Now
Haemonetics
$74.1638.89%Barrington Research
Michael Petusky
$94 → $103MaintainsOutperformGet Alert
02/08/2023HAEBuy Now
Haemonetics
$74.1655.07%Mizuho
Anthony Petrone
$110 → $115MaintainsBuyGet Alert
01/24/2023HAEBuy Now
Haemonetics
$74.1648.33%Mizuho
Anthony Petrone
$100 → $110MaintainsBuyGet Alert
01/06/2023HAEBuy Now
Haemonetics
$74.1613.27%Morgan Stanley
Drew Ranieri
$90 → $84MaintainsEqual-WeightGet Alert
12/12/2022HAEBuy Now
Haemonetics
$74.1624.06%Citigroup
Joanne Wuensch
$88 → $92MaintainsNeutralGet Alert
11/08/2022HAEBuy Now
Haemonetics
$74.1626.75%Barrington Research
Michael Petusky
$88 → $94MaintainsOutperformGet Alert
11/08/2022HAEBuy Now
Haemonetics
$74.1621.36%Morgan Stanley
Drew Ranieri
$85 → $90MaintainsEqual-WeightGet Alert
11/08/2022HAEBuy Now
Haemonetics
$74.1634.84%Mizuho
Anthony Petrone
$90 → $100MaintainsBuyGet Alert
11/08/2022HAEBuy Now
Haemonetics
$74.1641.59%JMP Securities
David Turkaly
$90 → $105MaintainsMarket OutperformGet Alert
11/08/2022HAEBuy Now
Haemonetics
$74.1634.84%Raymond James
Andrew Cooper
$88 → $100MaintainsOutperformGet Alert

FAQ

Q

What is the target price for Haemonetics (HAE)?

A

The latest price target for Haemonetics (NYSE: HAE) was reported by Barrington Research on February 13, 2024. The analyst firm set a price target for $105.00 expecting HAE to rise to within 12 months (a possible 41.59% upside). 7 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Haemonetics (HAE)?

A

The latest analyst rating for Haemonetics (NYSE: HAE) was provided by Barrington Research, and Haemonetics reiterated their outperform rating.

Q

When is the next analyst rating going to be posted or updated for Haemonetics (HAE)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Haemonetics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Haemonetics was filed on February 13, 2024 so you should expect the next rating to be made available sometime around February 13, 2025.

Q

Is the Analyst Rating Haemonetics (HAE) correct?

A

While ratings are subjective and will change, the latest Haemonetics (HAE) rating was a reiterated with a price target of $0.00 to $105.00. The current price Haemonetics (HAE) is trading at is $74.16, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch